Research and Development

Showing 15 posts of 9600 posts found.

Sanofi to develop monoclonal antibody jabs

June 8, 2010 Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …

EMA under fire for blocking data access

June 8, 2010 Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data

The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …

Idis appoints Richard Greatorex

June 8, 2010 Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing

Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …

Chiltern Achieves Supplementary Accreditation from the Medicines & Healthcare Products Regulatory Agency

June 7, 2010 Research and Development

Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, “In November 2007, the MHRA launched a voluntary accreditation scheme for …
Avastin packs

Avastin promising in ovarian cancer

June 7, 2010 Research and Development ASCO, avastin

Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …

UCB’s Kola joins Astex board

June 5, 2010 Research and Development Astex, UCB, appointment, research and development

Dr Ismail Kola has joined the board of directors at UK biotech company Astex Therapeutics. Astex’s non-executive chairman Peter Fellner …

Sanofi signs deal on pre-clinical cancer drugs

June 4, 2010 Research and Development Cancer, Sanofi

Sanofi-Aventis has signed a deal with US biotech company Ascenta to co-develop new oncology treatments aimed at restoring ‘apoptosis’ or …
ASCObag

ASCO cancer conference opens

June 4, 2010 Research and Development ASCO, Cancer, lenalidomide, rituximab

One of the most important dates in the pharmaceutical industry’s calendar, the ASCO cancer conference begins today. The American Society …

Vaccine for brain cancer shows promise

June 3, 2010 Research and Development Cancer, GBM, ImmunoCellular

Early stage trials of a new treatment for the brain cancer glioblastoma multiforme have shown promise. ICT-107 is being developed …

Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre

June 3, 2010 Research and Development

Chiltern will draw upon many parts of TAHSC, including the Clinical Research Centre (CRC) which is located on the same …

Contract research news in brief

June 1, 2010 Research and Development CRO, NIB

Irish contract research organisation ICON plc has acquired Timaq Medical Imaging, a Swiss provider of imaging services to pharmaceutical and …

Inspra performs strongly in heart failure patients

May 28, 2010 Research and Development, Sales and Marketing Inspra, Pfizer, chronic heart failure, heart failure

Pfizer is to end a clinical trial of Inspra early because of signs that it significantly cuts the risk of …

Pfizer R&D head exits for AstraZeneca

May 27, 2010 Research and Development AstraZeneca, Pfizer, appointment, research and development

One of Pfizer’s two heads of research and development Martin Mackay is to leave the company for rivals AstraZeneca. Only …

Sanofi signs biomedical collaboration with MIT

May 27, 2010 Research and Development MIT, Sanofi-Aventis, academia, biomedical

Sanofi-Aventis has formed a strategic alliance with the Centre for Biodmedical Innovation  at the Massachusetts Institute of Technology. The alliance, …

Roche forms translational medicine research hub

May 26, 2010 Research and Development Roche, Switzerland, academic research, translational

Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …
The Gateway to Local Adoption Series

Latest content